The study findings to be presented by MD Anderson Cancer Center at 60th Annual Hematology Meeting in San Diego, CA.

Industry leaders gather in Cambridge, MA on December 5th to discuss innovative methods for accelerating antibody discovery.

Award recognizes company's products as innovative, revolutionary and able to fulfil the needs of customers.

If you currently use FBS, or are planning to do so, we would greatly appreciate your feedback. We estimate the survey will take about 5 minute to complete.

Gene editing technology will be used to develop cell models for optimized metabolic disease drug development.

New Silencer Select IncRNAs siRNAs offer up to 90 percent knockdown of lncRNA.

Representing genomic tools for mission critical customer applications.

Following successful European rollout, more customers to benefit from enhanced local sales and support services.

New E. coli-based Cell-Free Expression System will accelerate synthetic biology research and protein discovery through expression from PCR products and gene fragments.

CRISPR is a key enabler for gene therapy.